▶ 調査レポート

アレルギー性鼻炎治療薬の世界市場2023:抗ヒスタミン薬、点鼻ステロイド薬、抗ロイコトリエン薬

• 英文タイトル:Global Allergic Rhinitis Medication Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Allergic Rhinitis Medication Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029「アレルギー性鼻炎治療薬の世界市場2023:抗ヒスタミン薬、点鼻ステロイド薬、抗ロイコトリエン薬」(市場規模、市場予測)調査レポートです。• レポートコード:MRC308GR11344
• 出版社/出版日:GlobalInfoResearch / 2023年8月
• レポート形態:英文、PDF、108ページ
• 納品方法:Eメール(2-3営業日)
• 産業分類:医薬品&ヘルスケア
• 販売価格(消費税別)
  Single User¥522,000 (USD3,480)▷ お問い合わせ
  Corporate User¥783,000 (USD5,220)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要

GlobalInfoResearchの最新の調査によると、世界のアレルギー性鼻炎治療薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。

このレポートは、世界のアレルギー性鼻炎治療薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– アレルギー性鼻炎治療薬の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため

アレルギー性鼻炎治療薬市場は種類と用途によって区分されます。2018年~2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・抗ヒスタミン薬、点鼻ステロイド薬、抗ロイコトリエン薬

用途別セグメント
・季節性アレルギー、通年性アレルギー

主要な市場プレーヤー
・Stallergenes Greer、AstraZeneca、Lotus、GSK、Neurent Medical、Hikma Pharmaceuticals、Med Globe Therapeutics Limited、Bayer Global、Taiho Pharmaceutical、Regeneron Pharmaceuticals、Glenmark

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、アレルギー性鼻炎治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なアレルギー性鼻炎治療薬メーカーの企業概要、2019年~2022年までのアレルギー性鼻炎治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なアレルギー性鼻炎治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年~2029年までの地域別アレルギー性鼻炎治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年~2029年までのアレルギー性鼻炎治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2029年までの主要地域でのアレルギー性鼻炎治療薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびアレルギー性鼻炎治療薬の産業チェーンを掲載しています。
・第14、15章では、アレルギー性鼻炎治療薬の販売チャネル、販売業者、顧客、調査結果について説明します。

***** 目次(一部) *****

・市場概要
– アレルギー性鼻炎治療薬の概要
– 種類別分析(2018年vs2022年vs2029年):抗ヒスタミン薬、点鼻ステロイド薬、抗ロイコトリエン薬
– 用途別分析(2018年vs2022年vs2029年):季節性アレルギー、通年性アレルギー
– 世界のアレルギー性鼻炎治療薬市場規模・予測
– 世界のアレルギー性鼻炎治療薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
– Stallergenes Greer、AstraZeneca、Lotus、GSK、Neurent Medical、Hikma Pharmaceuticals、Med Globe Therapeutics Limited、Bayer Global、Taiho Pharmaceutical、Regeneron Pharmaceuticals、Glenmark
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年:抗ヒスタミン薬、点鼻ステロイド薬、抗ロイコトリエン薬
・用途別分析2018年-2029年:季節性アレルギー、通年性アレルギー
・アレルギー性鼻炎治療薬の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:アメリカ、カナダ、メキシコなど
・アレルギー性鼻炎治療薬のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・アレルギー性鼻炎治療薬のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・アレルギー性鼻炎治療薬の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:ブラジル、アルゼンチンなど
・アレルギー性鼻炎治療薬の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学(成長要因、阻害要因、トレンド、ポーターズファイブフォース分析)
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Allergic Rhinitis Medication
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Allergic Rhinitis Medication Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Antihistamines
1.3.3 Nasal Spray Steroids
1.3.4 Antileukotrienes
1.4 Market Analysis by Application
1.4.1 Overview: Global Allergic Rhinitis Medication Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Seasonal Allergies
1.4.3 Perennial Allergies
1.5 Global Allergic Rhinitis Medication Market Size & Forecast
1.5.1 Global Allergic Rhinitis Medication Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Allergic Rhinitis Medication Sales Quantity (2018-2029)
1.5.3 Global Allergic Rhinitis Medication Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Stallergenes Greer
2.1.1 Stallergenes Greer Details
2.1.2 Stallergenes Greer Major Business
2.1.3 Stallergenes Greer Allergic Rhinitis Medication Product and Services
2.1.4 Stallergenes Greer Allergic Rhinitis Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Stallergenes Greer Recent Developments/Updates
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Allergic Rhinitis Medication Product and Services
2.2.4 AstraZeneca Allergic Rhinitis Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 AstraZeneca Recent Developments/Updates
2.3 Lotus
2.3.1 Lotus Details
2.3.2 Lotus Major Business
2.3.3 Lotus Allergic Rhinitis Medication Product and Services
2.3.4 Lotus Allergic Rhinitis Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Lotus Recent Developments/Updates
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK Allergic Rhinitis Medication Product and Services
2.4.4 GSK Allergic Rhinitis Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 GSK Recent Developments/Updates
2.5 Neurent Medical
2.5.1 Neurent Medical Details
2.5.2 Neurent Medical Major Business
2.5.3 Neurent Medical Allergic Rhinitis Medication Product and Services
2.5.4 Neurent Medical Allergic Rhinitis Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Neurent Medical Recent Developments/Updates
2.6 Hikma Pharmaceuticals
2.6.1 Hikma Pharmaceuticals Details
2.6.2 Hikma Pharmaceuticals Major Business
2.6.3 Hikma Pharmaceuticals Allergic Rhinitis Medication Product and Services
2.6.4 Hikma Pharmaceuticals Allergic Rhinitis Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Hikma Pharmaceuticals Recent Developments/Updates
2.7 Med Globe Therapeutics Limited
2.7.1 Med Globe Therapeutics Limited Details
2.7.2 Med Globe Therapeutics Limited Major Business
2.7.3 Med Globe Therapeutics Limited Allergic Rhinitis Medication Product and Services
2.7.4 Med Globe Therapeutics Limited Allergic Rhinitis Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Med Globe Therapeutics Limited Recent Developments/Updates
2.8 Bayer Global
2.8.1 Bayer Global Details
2.8.2 Bayer Global Major Business
2.8.3 Bayer Global Allergic Rhinitis Medication Product and Services
2.8.4 Bayer Global Allergic Rhinitis Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bayer Global Recent Developments/Updates
2.9 Taiho Pharmaceutical
2.9.1 Taiho Pharmaceutical Details
2.9.2 Taiho Pharmaceutical Major Business
2.9.3 Taiho Pharmaceutical Allergic Rhinitis Medication Product and Services
2.9.4 Taiho Pharmaceutical Allergic Rhinitis Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Taiho Pharmaceutical Recent Developments/Updates
2.10 Regeneron Pharmaceuticals
2.10.1 Regeneron Pharmaceuticals Details
2.10.2 Regeneron Pharmaceuticals Major Business
2.10.3 Regeneron Pharmaceuticals Allergic Rhinitis Medication Product and Services
2.10.4 Regeneron Pharmaceuticals Allergic Rhinitis Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Regeneron Pharmaceuticals Recent Developments/Updates
2.11 Glenmark
2.11.1 Glenmark Details
2.11.2 Glenmark Major Business
2.11.3 Glenmark Allergic Rhinitis Medication Product and Services
2.11.4 Glenmark Allergic Rhinitis Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Glenmark Recent Developments/Updates
3 Competitive Environment: Allergic Rhinitis Medication by Manufacturer
3.1 Global Allergic Rhinitis Medication Sales Quantity by Manufacturer (2018-2023)
3.2 Global Allergic Rhinitis Medication Revenue by Manufacturer (2018-2023)
3.3 Global Allergic Rhinitis Medication Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Allergic Rhinitis Medication by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Allergic Rhinitis Medication Manufacturer Market Share in 2022
3.4.2 Top 6 Allergic Rhinitis Medication Manufacturer Market Share in 2022
3.5 Allergic Rhinitis Medication Market: Overall Company Footprint Analysis
3.5.1 Allergic Rhinitis Medication Market: Region Footprint
3.5.2 Allergic Rhinitis Medication Market: Company Product Type Footprint
3.5.3 Allergic Rhinitis Medication Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Allergic Rhinitis Medication Market Size by Region
4.1.1 Global Allergic Rhinitis Medication Sales Quantity by Region (2018-2029)
4.1.2 Global Allergic Rhinitis Medication Consumption Value by Region (2018-2029)
4.1.3 Global Allergic Rhinitis Medication Average Price by Region (2018-2029)
4.2 North America Allergic Rhinitis Medication Consumption Value (2018-2029)
4.3 Europe Allergic Rhinitis Medication Consumption Value (2018-2029)
4.4 Asia-Pacific Allergic Rhinitis Medication Consumption Value (2018-2029)
4.5 South America Allergic Rhinitis Medication Consumption Value (2018-2029)
4.6 Middle East and Africa Allergic Rhinitis Medication Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Allergic Rhinitis Medication Sales Quantity by Type (2018-2029)
5.2 Global Allergic Rhinitis Medication Consumption Value by Type (2018-2029)
5.3 Global Allergic Rhinitis Medication Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Allergic Rhinitis Medication Sales Quantity by Application (2018-2029)
6.2 Global Allergic Rhinitis Medication Consumption Value by Application (2018-2029)
6.3 Global Allergic Rhinitis Medication Average Price by Application (2018-2029)
7 North America
7.1 North America Allergic Rhinitis Medication Sales Quantity by Type (2018-2029)
7.2 North America Allergic Rhinitis Medication Sales Quantity by Application (2018-2029)
7.3 North America Allergic Rhinitis Medication Market Size by Country
7.3.1 North America Allergic Rhinitis Medication Sales Quantity by Country (2018-2029)
7.3.2 North America Allergic Rhinitis Medication Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Allergic Rhinitis Medication Sales Quantity by Type (2018-2029)
8.2 Europe Allergic Rhinitis Medication Sales Quantity by Application (2018-2029)
8.3 Europe Allergic Rhinitis Medication Market Size by Country
8.3.1 Europe Allergic Rhinitis Medication Sales Quantity by Country (2018-2029)
8.3.2 Europe Allergic Rhinitis Medication Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Allergic Rhinitis Medication Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Allergic Rhinitis Medication Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Allergic Rhinitis Medication Market Size by Region
9.3.1 Asia-Pacific Allergic Rhinitis Medication Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Allergic Rhinitis Medication Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Allergic Rhinitis Medication Sales Quantity by Type (2018-2029)
10.2 South America Allergic Rhinitis Medication Sales Quantity by Application (2018-2029)
10.3 South America Allergic Rhinitis Medication Market Size by Country
10.3.1 South America Allergic Rhinitis Medication Sales Quantity by Country (2018-2029)
10.3.2 South America Allergic Rhinitis Medication Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Allergic Rhinitis Medication Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Allergic Rhinitis Medication Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Allergic Rhinitis Medication Market Size by Country
11.3.1 Middle East & Africa Allergic Rhinitis Medication Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Allergic Rhinitis Medication Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Allergic Rhinitis Medication Market Drivers
12.2 Allergic Rhinitis Medication Market Restraints
12.3 Allergic Rhinitis Medication Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Allergic Rhinitis Medication and Key Manufacturers
13.2 Manufacturing Costs Percentage of Allergic Rhinitis Medication
13.3 Allergic Rhinitis Medication Production Process
13.4 Allergic Rhinitis Medication Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Allergic Rhinitis Medication Typical Distributors
14.3 Allergic Rhinitis Medication Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Allergic Rhinitis Medication Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Allergic Rhinitis Medication Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Stallergenes Greer Basic Information, Manufacturing Base and Competitors
Table 4. Stallergenes Greer Major Business
Table 5. Stallergenes Greer Allergic Rhinitis Medication Product and Services
Table 6. Stallergenes Greer Allergic Rhinitis Medication Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Stallergenes Greer Recent Developments/Updates
Table 8. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 9. AstraZeneca Major Business
Table 10. AstraZeneca Allergic Rhinitis Medication Product and Services
Table 11. AstraZeneca Allergic Rhinitis Medication Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. AstraZeneca Recent Developments/Updates
Table 13. Lotus Basic Information, Manufacturing Base and Competitors
Table 14. Lotus Major Business
Table 15. Lotus Allergic Rhinitis Medication Product and Services
Table 16. Lotus Allergic Rhinitis Medication Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Lotus Recent Developments/Updates
Table 18. GSK Basic Information, Manufacturing Base and Competitors
Table 19. GSK Major Business
Table 20. GSK Allergic Rhinitis Medication Product and Services
Table 21. GSK Allergic Rhinitis Medication Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. GSK Recent Developments/Updates
Table 23. Neurent Medical Basic Information, Manufacturing Base and Competitors
Table 24. Neurent Medical Major Business
Table 25. Neurent Medical Allergic Rhinitis Medication Product and Services
Table 26. Neurent Medical Allergic Rhinitis Medication Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Neurent Medical Recent Developments/Updates
Table 28. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Hikma Pharmaceuticals Major Business
Table 30. Hikma Pharmaceuticals Allergic Rhinitis Medication Product and Services
Table 31. Hikma Pharmaceuticals Allergic Rhinitis Medication Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Hikma Pharmaceuticals Recent Developments/Updates
Table 33. Med Globe Therapeutics Limited Basic Information, Manufacturing Base and Competitors
Table 34. Med Globe Therapeutics Limited Major Business
Table 35. Med Globe Therapeutics Limited Allergic Rhinitis Medication Product and Services
Table 36. Med Globe Therapeutics Limited Allergic Rhinitis Medication Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Med Globe Therapeutics Limited Recent Developments/Updates
Table 38. Bayer Global Basic Information, Manufacturing Base and Competitors
Table 39. Bayer Global Major Business
Table 40. Bayer Global Allergic Rhinitis Medication Product and Services
Table 41. Bayer Global Allergic Rhinitis Medication Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Bayer Global Recent Developments/Updates
Table 43. Taiho Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Taiho Pharmaceutical Major Business
Table 45. Taiho Pharmaceutical Allergic Rhinitis Medication Product and Services
Table 46. Taiho Pharmaceutical Allergic Rhinitis Medication Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Taiho Pharmaceutical Recent Developments/Updates
Table 48. Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 49. Regeneron Pharmaceuticals Major Business
Table 50. Regeneron Pharmaceuticals Allergic Rhinitis Medication Product and Services
Table 51. Regeneron Pharmaceuticals Allergic Rhinitis Medication Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Regeneron Pharmaceuticals Recent Developments/Updates
Table 53. Glenmark Basic Information, Manufacturing Base and Competitors
Table 54. Glenmark Major Business
Table 55. Glenmark Allergic Rhinitis Medication Product and Services
Table 56. Glenmark Allergic Rhinitis Medication Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Glenmark Recent Developments/Updates
Table 58. Global Allergic Rhinitis Medication Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Allergic Rhinitis Medication Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Allergic Rhinitis Medication Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Allergic Rhinitis Medication, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Allergic Rhinitis Medication Production Site of Key Manufacturer
Table 63. Allergic Rhinitis Medication Market: Company Product Type Footprint
Table 64. Allergic Rhinitis Medication Market: Company Product Application Footprint
Table 65. Allergic Rhinitis Medication New Market Entrants and Barriers to Market Entry
Table 66. Allergic Rhinitis Medication Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Allergic Rhinitis Medication Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Allergic Rhinitis Medication Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Allergic Rhinitis Medication Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Allergic Rhinitis Medication Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Allergic Rhinitis Medication Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Allergic Rhinitis Medication Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Allergic Rhinitis Medication Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Allergic Rhinitis Medication Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Allergic Rhinitis Medication Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Allergic Rhinitis Medication Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Allergic Rhinitis Medication Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Allergic Rhinitis Medication Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Allergic Rhinitis Medication Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Allergic Rhinitis Medication Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Allergic Rhinitis Medication Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Allergic Rhinitis Medication Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Allergic Rhinitis Medication Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Allergic Rhinitis Medication Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Allergic Rhinitis Medication Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Allergic Rhinitis Medication Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Allergic Rhinitis Medication Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Allergic Rhinitis Medication Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Allergic Rhinitis Medication Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Allergic Rhinitis Medication Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Allergic Rhinitis Medication Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Allergic Rhinitis Medication Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Allergic Rhinitis Medication Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Allergic Rhinitis Medication Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Allergic Rhinitis Medication Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Allergic Rhinitis Medication Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Allergic Rhinitis Medication Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Allergic Rhinitis Medication Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Allergic Rhinitis Medication Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Allergic Rhinitis Medication Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Allergic Rhinitis Medication Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Allergic Rhinitis Medication Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Allergic Rhinitis Medication Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Allergic Rhinitis Medication Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Allergic Rhinitis Medication Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Allergic Rhinitis Medication Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Allergic Rhinitis Medication Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Allergic Rhinitis Medication Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Allergic Rhinitis Medication Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Allergic Rhinitis Medication Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Allergic Rhinitis Medication Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Allergic Rhinitis Medication Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Allergic Rhinitis Medication Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Allergic Rhinitis Medication Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Allergic Rhinitis Medication Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Allergic Rhinitis Medication Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Allergic Rhinitis Medication Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Allergic Rhinitis Medication Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Allergic Rhinitis Medication Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Allergic Rhinitis Medication Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Allergic Rhinitis Medication Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Allergic Rhinitis Medication Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Allergic Rhinitis Medication Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Allergic Rhinitis Medication Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Allergic Rhinitis Medication Raw Material
Table 126. Key Manufacturers of Allergic Rhinitis Medication Raw Materials
Table 127. Allergic Rhinitis Medication Typical Distributors
Table 128. Allergic Rhinitis Medication Typical Customers
List of Figures
Figure 1. Allergic Rhinitis Medication Picture
Figure 2. Global Allergic Rhinitis Medication Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Allergic Rhinitis Medication Consumption Value Market Share by Type in 2022
Figure 4. Antihistamines Examples
Figure 5. Nasal Spray Steroids Examples
Figure 6. Antileukotrienes Examples
Figure 7. Global Allergic Rhinitis Medication Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Allergic Rhinitis Medication Consumption Value Market Share by Application in 2022
Figure 9. Seasonal Allergies Examples
Figure 10. Perennial Allergies Examples
Figure 11. Global Allergic Rhinitis Medication Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Allergic Rhinitis Medication Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Allergic Rhinitis Medication Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Allergic Rhinitis Medication Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Allergic Rhinitis Medication Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Allergic Rhinitis Medication Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Allergic Rhinitis Medication by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Allergic Rhinitis Medication Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Allergic Rhinitis Medication Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Allergic Rhinitis Medication Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Allergic Rhinitis Medication Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Allergic Rhinitis Medication Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Allergic Rhinitis Medication Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Allergic Rhinitis Medication Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Allergic Rhinitis Medication Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Allergic Rhinitis Medication Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Allergic Rhinitis Medication Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Allergic Rhinitis Medication Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Allergic Rhinitis Medication Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Allergic Rhinitis Medication Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Allergic Rhinitis Medication Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Allergic Rhinitis Medication Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Allergic Rhinitis Medication Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Allergic Rhinitis Medication Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Allergic Rhinitis Medication Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Allergic Rhinitis Medication Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Allergic Rhinitis Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Allergic Rhinitis Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Allergic Rhinitis Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Allergic Rhinitis Medication Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Allergic Rhinitis Medication Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Allergic Rhinitis Medication Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Allergic Rhinitis Medication Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Allergic Rhinitis Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Allergic Rhinitis Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Allergic Rhinitis Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Allergic Rhinitis Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Allergic Rhinitis Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Allergic Rhinitis Medication Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Allergic Rhinitis Medication Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Allergic Rhinitis Medication Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Allergic Rhinitis Medication Consumption Value Market Share by Region (2018-2029)
Figure 53. China Allergic Rhinitis Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Allergic Rhinitis Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Allergic Rhinitis Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Allergic Rhinitis Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Allergic Rhinitis Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Allergic Rhinitis Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Allergic Rhinitis Medication Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Allergic Rhinitis Medication Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Allergic Rhinitis Medication Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Allergic Rhinitis Medication Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Allergic Rhinitis Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Allergic Rhinitis Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Allergic Rhinitis Medication Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Allergic Rhinitis Medication Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Allergic Rhinitis Medication Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Allergic Rhinitis Medication Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Allergic Rhinitis Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Allergic Rhinitis Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Allergic Rhinitis Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Allergic Rhinitis Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Allergic Rhinitis Medication Market Drivers
Figure 74. Allergic Rhinitis Medication Market Restraints
Figure 75. Allergic Rhinitis Medication Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Allergic Rhinitis Medication in 2022
Figure 78. Manufacturing Process Analysis of Allergic Rhinitis Medication
Figure 79. Allergic Rhinitis Medication Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source